{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:10:34Z","timestamp":1793729434661,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.anndiagpath.2022.152079","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T20:24:55Z","timestamp":1670876695000},"page":"152079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder"],"prefix":"10.1016","volume":"63","author":[{"given":"Madiha","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Loya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurrum","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudassar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umer Nisar","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2022.152079_bb0005","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0010","series-title":"Classification of male genitourinary tumors","author":"WHO","year":"2022"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in Situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0025","article-title":"Substaging of pT1 urothelial bladder carcinoma predicts tumor progression and overall survival","volume":"1\u20138","author":"Grobet-Jeandin","year":"2021","journal-title":"Urol Int"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel[Formula present","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0035","article-title":"International society of urological pathology expert opinion on grading of urothelial carcinoma","author":"Van der Kwast","year":"2021","journal-title":"Eur UrolFocus"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0040","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8","article-title":"Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2015.09.007","article-title":"Significance of a minor high-grade component in a low-grade non-invasive papillary urothelial carcinoma of bladder","volume":"47","author":"Reis","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0050","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.juro.2013.11.056","article-title":"Mixed high and low grade bladder tumors\u2013are they clinically high or low grade?","volume":"191","author":"Gofrit","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0055","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4274\/MMJ.galenos.2021.48447","article-title":"The clinical impact of tumor heterogeneity in non-muscle invasive urothelial carcinoma of the bladder","volume":"36","author":"Culpan","year":"2021","journal-title":"Medeni Med J"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/PAP.0000000000000308","article-title":"The Genitourinary Pathology Society Update on classification and grading of flat and papillary urothelial neoplasia with new reporting recommendations and approach to lesions with mixed and early patterns of neoplasia","volume":"28","author":"Amin","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"21","key":"10.1016\/j.anndiagpath.2022.152079_bb0065","first-page":"00304","article-title":"The effect of tumor grade heterogeneity on recurrence in non-muscle invasive bladder cancer","volume":"S1078\u20131439","author":"Ho","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0070","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00345-014-1383-5","article-title":"Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome","volume":"33","author":"Schubert","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrurol.2018.2","article-title":"A practical guide to bladder cancer pathology","volume":"15","author":"Comp\u00e9rat","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.eururo.2013.10.001","article-title":"International variations in bladder cancer incidence and mortality","volume":"66","author":"Chavan","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0090","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00428-013-1456-7","article-title":"Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance","volume":"463","author":"Mai","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0095","series-title":"Guidelines on non-muscle invasive bladder cancer (TaT1 and CIS)","author":"Babjuk","year":"2012"},{"key":"10.1016\/j.anndiagpath.2022.152079_bb0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2005.12.029","article-title":"Watchful waiting policy in recurrent ta G1 bladder tumors","volume":"49","author":"Gofrit","year":"2006","journal-title":"Eur Urol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422001812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422001812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:34:59Z","timestamp":1761078899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913422001812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"alternative-id":["S1092913422001812"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152079","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152079"}}